Adragos Hub

Batch size planning for semi-solid CDMO production is one of the least glamorous and most consequential decisions in a commercial programme. Choose a batch size that is too large and you tie up capital, risk waste and lose flexibility. Choose […]

Knowing how to evaluate a small molecule CDMO is what stands between a smooth development programme and an expensive misstep. A small molecule Contract Development and Manufacturing Organization (CDMO) takes an active ingredient and turns it into a formulated, tested, […]

GMP compliance for CDMO manufacturing is the set of Good Manufacturing Practice standards that a Contract Development and Manufacturing Organization (CDMO) must meet to produce medicines safely, consistently and in a way that regulators will accept. When a pharmaceutical or […]

What Is GMP Compliance for CDMO Manufacturing? Contents What Is Good Manufacturing Practice Compliance for a CDMO? Good Manufacturing Practice Certifications to Assess When Selecting a CDMO Aseptic Manufacturing Standards for Injectable Production Good Manufacturing Practice Requirements for Semi-Solid Dosage […]

CDMO Tech Transfer: Semi-Solids & Injectables | Adragos Technology transfer to a contract development and manufacturing organisation (CDMO) for semi-solid or sterile injectable pharmaceutical products is a structured, multi-stage programme through which a product’s formulation, manufacturing process and quality control […]

A sterile injectable CDMO from clinical to commercial is a partner that can take your product all the way from its first Phase I batches to full commercial supply, without forcing a change of site along the way. That journey […]